Perspective Therapeutics (CATX) Property, Plant & Equipment (Net) (2011 - 2026)
Perspective Therapeutics (CATX) Property, Plant & Equipment (Net) (2011 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.10 Bn | 176.81 Bn | 6.27 Bn | 12.38 Bn |
| 2 | Stryker | 128.79 Bn | 125.91 Bn | 3.81 Bn | 3.89 Bn |
| 3 | Medtronic | 108.97 Bn | 99.75 Bn | 6.41 Bn | 7.42 Bn |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn | 4.06 Bn |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | 1.82 Bn |
| 6 | GE HealthCare Technologies | 28.40 Bn | 26.11 Bn | 1.98 Bn | 3.10 Bn |
| 7 | Dexcom | 28.32 Bn | 27.20 Bn | 750.30 Mn | 1.56 Bn |
| 8 | Smith & Nephew | 26.94 Bn | 26.36 Bn | - | 6.35 Bn |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | 2.55 Bn |
| 10 | Perspective Therapeutics | 303.56 Mn | 303.56 Mn | - | 92.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 92.48 Mn |
| Mar 31, 2026 | 92.48 Mn |
| Dec 31, 2025 | 76.60 Mn |
| Dec 31, 2025 | 76.60 Mn |
| Sep 30, 2025 | 64.35 Mn |
| Sep 30, 2025 | 64.35 Mn |
| Jun 30, 2025 | 62.60 Mn |
| Jun 30, 2025 | 62.60 Mn |
| Mar 31, 2025 | 61.25 Mn |
| Mar 31, 2025 | 61.25 Mn |
| Dec 31, 2024 | 57.32 Mn |
| Dec 31, 2024 | 57.32 Mn |
| Sep 30, 2024 | 43.79 Mn |
| Sep 30, 2024 | 43.79 Mn |
| Jun 30, 2024 | 14.75 Mn |
| Jun 30, 2024 | 14.75 Mn |
| Mar 31, 2024 | 14.30 Mn |
| Mar 31, 2024 | 14.30 Mn |
| Dec 31, 2023 | 5.58 Mn |
| Dec 31, 2023 | 5.58 Mn |